Patents by Inventor Brooks Henningsen

Brooks Henningsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240191263
    Abstract: The present disclosure concerns a symbiotic combination of a bacterial host cell and a yeast host cell selected or engineered to utilize glycerol to reduce greenhouse gases during the production of ethanol from a biomass comprising hexoses.
    Type: Application
    Filed: December 12, 2023
    Publication date: June 13, 2024
    Inventors: Jeffery R. Broadbent, James L. Steele, Brooks Henningsen, Ekkarat Phrommao, Fernanda Cristina Firmino
  • Publication number: 20240191262
    Abstract: The present disclosure concerns a symbiotic combination of a bacterial host cell and a yeast host cell selected or engineered to utilize glycerol to reduce greenhouse gases during the production of ethanol from a biomass comprising pentoses.
    Type: Application
    Filed: December 12, 2023
    Publication date: June 13, 2024
    Inventors: Jeffery R. Broadbent, James L. Steele, Brooks Henningsen, Ekkarat Phrommao, Fernanda Cristina Firmino
  • Patent number: 11999987
    Abstract: The present disclosure concerns a co-culture of bacterial cells for making a fermented product from a biomass. The co-culture comprising a first recombinant lactic acid bacteria (LAB) cell expressing at least one bacteriocin and a second recombinant lactic acid bacteria (LAB) cell capable of converting, at least in part, the biomass into the fermented product. The second recombinant LAB cell is immune to the bacteriocin produced by the first recombinant LAB cell. The co-culture can be used, optionally in combination with a yeast host cell, to make a fermented product. The present disclosure also provides processes for making the fermented product by using the co-culture as wells kits and media comprising the co-culture.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: June 4, 2024
    Assignee: Lallemand Hungary Liquidity Management LLC
    Inventors: James L. Steele, Brooks Henningsen, Jeffery R. Broadbent, Ekkarat Phrommao, Fernanda Cristina Firmino
  • Patent number: 11739338
    Abstract: Acetate is a potent microbial inhibitor which can affect the performance of yeast in ethanolic fermentation. The present disclosure provides a recombinant microbial host cell having (i) a first genetic modification for increasing the activity of one or more proteins that function in a first metabolic pathway to convert acetate into an alcohol in the microbial host cell; (ii) a second genetic modification for increasing the activity of one or more proteins that function in a second metabolic pathway to import glycerol in the recombinant microbial host cell (iii) a third genetic modification for increasing the activity of one or more proteins that function in a third metabolic pathway to convert a C5 carbohydrate into ethanol in the microbial host cell. The recombinant microbial host cell comprises and natively expresses native proteins that function in a fourth native metabolic pathway to produce glycerol in the microbial host cell.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: August 29, 2023
    Assignee: LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC
    Inventors: Brooks Henningsen, Sean Covalla, Rintze Zelle, Allan Froehlich
  • Patent number: 11667680
    Abstract: The present disclosure relates to the modulation in the RAS/cAMP/PKA signaling pathway for maintaining the propagation efficiency and increasing fermentation efficiency of yeast cells. The present disclosure provides yeast cells having or engineered to exhibit a modulation in signaling in a RAS/cAMP/PKA pathway, depending on conditions. For example the yeast cells can be selected or genetically modified to express a mutated Ras1 protein, a mutated Ras2 protein, a mutated Ira1 protein and/or a mutated Ira2 protein, optionally in combination with specific promoters. Also provided herewith are methods for propagating the yeast cells as well as using the yeast cells to generate a fermented product (such as ethanol).
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: June 6, 2023
    Assignee: Lallemand Hungary Liquidity Management LLC
    Inventors: Michelle Oeser, Brooks Henningsen, Janet Fisher, Charles F. Rice, Allan Froehlich, Aaron Argyros, Rintze M. Zelle
  • Publication number: 20220228176
    Abstract: The present disclosure concerns a symbiotic combination of host cells engineered to produce a first metabolic product, for example a carbohydrate, and to convert the second metabolic product into a second metabolic product, for example an alcohol.
    Type: Application
    Filed: November 13, 2019
    Publication date: July 21, 2022
    Inventors: Jeffery R. Broadbent, Aaron Argyros, Brooks Henningsen, Fernanda Cristina Firmino, Ekkarat Phrommao, James L. Steele
  • Publication number: 20220154113
    Abstract: The present disclosure concerns recombinant yeast host cells expressing one or more heterologous polypeptide for making a flavour compound and a native ethanol production pathway. The recombinant yeast host cells can be used in a subsequent production process to make flavoured alcoholic beverage products, such as beers.
    Type: Application
    Filed: March 1, 2019
    Publication date: May 19, 2022
    Inventors: Charles F. Rice, Emily Agnes Stonehouse, Nicholas Memmer, Jared Cameron Muysson, Bailey Morgan Carignan, Christopher J. Freeman, Brooks Henningsen, Hannah Lena Green, Aaron Argyros
  • Publication number: 20220127564
    Abstract: The present disclosure concerns recombinant yeast host cells expressing cell-associated heterologous proteins which are expressed during the propagation phase of the recombinant yeast host cells and processes for propagating same. The recombinant yeast host cells can be 5 used to make a yeast composition or a yeast product enriched in the heterologous proteins.
    Type: Application
    Filed: March 13, 2018
    Publication date: April 28, 2022
    Inventors: Aaron Argyros, Michelle Oeser, Erin Wiswall, Janet Fisher, Johannes Van Eijk, J. Kevin Kraus, Kevin Wenger, Brooks Henningsen, Ryan Skinner
  • Patent number: 11306304
    Abstract: There is provided an engineered host cells comprising (a) one or more mutations in one or more endogenous genes encoding a protein associated with iron metabolism; and (b) at least one gene encoding a polypeptide having xylose isomerase activity, and methods of their use thereof.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: April 19, 2022
    Assignee: Lallemand Hungary Liquidity Management LLC
    Inventors: Allan Froehlich, Brooks Henningsen, Sean Covalla, Rintze M. Zelle
  • Publication number: 20220007683
    Abstract: Fermentation by-products can be used in feed to provide nutrients to animals. The present disclosure concerns a process for modulating the nutritional content in a whole stillage. The process includes fermenting a biomass in the presence of a recombinant lactic acid bacteria (LAB) cell and a yeast with a biomass and recuperating the whole stillage once the fermentation has been completed. The recombinant LAB is capable of expressing one or more first heterologous enzyme for converting the biomass into the fermentation product.
    Type: Application
    Filed: July 9, 2021
    Publication date: January 13, 2022
    Inventors: James L. Steele, Brooks Henningsen, Jeffery R. Broadbent, Ekkarat Phrommao, Fernanda Cristina Firmino
  • Publication number: 20220010340
    Abstract: The present disclosure concerns a recombinant bacterial host cell capable of providing a nitrogen source to a yeast during fermentation to make ethanol. The recombinant bacterial host cell is capable of converting a biomass into ethanol. The recombinant bacterial host cell has at least one first genetic modification. The at least one genetic modifications confers to the recombinant bacterial host cell the ability to increase, when compared to a corresponding control bacterial cell lacking the at least one first genetic modification, the proteolytic activity associated with the recombinant bacterial host cell. The at least one genetic modification also confers the recombinant bacterial host cell the ability to provide a nitrogen source to a yeast capable of converting the biomass into ethanol, wherein the nitrogen source comprises a peptide, an amino acid and/or ammonia.
    Type: Application
    Filed: July 9, 2021
    Publication date: January 13, 2022
    Inventors: James L. Steele, Brooks Henningsen, Jeffery R. Broadbent, Ekkarat Phrommao, Fernanda Cristina Firmino
  • Publication number: 20220010265
    Abstract: The present disclosure provides an antimicrobial composition as well as a process using same to limit microbial activity in a yeast medium. The antimicrobial composition includes at least one weak acid, optionally in combination with an acid stable bacteriocin and/or an antibiotic. The antimicrobial composition can be used for propagating yeasts and for making a fermentation product. The present disclosure also provides yeasts and lactic acid bacteria that can be used with the antimicrobial composition.
    Type: Application
    Filed: July 9, 2021
    Publication date: January 13, 2022
    Inventors: Jeffery R. Broadbent, James L. Steele, Brooks Henningsen, Ekkarat Phrommao, Fernanda Cristina Firmino
  • Publication number: 20210292803
    Abstract: The present disclosure concerns a co-culture of bacterial cells for making a fermented product from a biomass. The co-culture comprising a first recombinant lactic acid bacteria (LAB) cell expressing at least one bacteriocin and a second recombinant lactic acid bacteria (LAB) cell capable of converting, at least in part, the biomass into the fermented product. The second recombinant LAB cell is immune to the bacteriocin produced by the first recombinant LAB cell. The co-culture can be used, optionally in combination with a yeast host cell, to make a fermented product. The present disclosure also provides processes for making the fermented product by using the co-culture as wells kits and media comprising the co-culture.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 23, 2021
    Inventors: James L. Steele, Brooks Henningsen, Jeffery R. Broadbent, Ekkarat Phrommao, Fernanda Cristina Firmino
  • Patent number: 11034949
    Abstract: There is provided chimeric polypeptides capable of converting xylose to xylulose, engineered host cells that express the chimeric polypeptides, methods of creating chimeric polypeptides, and methods of fermenting cellulosic biomass to produce biofuels, including ethanol.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: June 15, 2021
    Assignee: Lallemand Hungary Liquidity Management LLC
    Inventors: Allan Froehlich, Brooks Henningsen
  • Publication number: 20210155944
    Abstract: Acetate is a potent microbial inhibitor which can affect the performance of yeast in ethanolic fermentation. The present disclosure provides a recombinant microbial host cell having (i) a first genetic modification for increasing the activity of one or more proteins that function in a first metabolic pathway to convert acetate into an alcohol in the microbial host cell; (ii) a second genetic modification for increasing the activity of one or more proteins that function in a second metabolic pathway to import glycerol in the recombinant microbial host cell (iii) a third genetic modification for increasing the activity of one or more proteins that function in a third metabolic pathway to convert a C5 carbohydrate into ethanol in the microbial host cell. The recombinant microbial host cell comprises and natively expresses native proteins that function in a fourth native metabolic pathway to produce glycerol in the microbial host cell.
    Type: Application
    Filed: September 18, 2018
    Publication date: May 27, 2021
    Inventors: Brooks Henningsen, Sean Covalla, Rintze Zelle, Allan Froehlich
  • Publication number: 20200248165
    Abstract: There is provided chimeric polypeptides capable of converting xylose to xylulose, engineered host cells that express the chimeric polypeptides, methods of creating chimeric polypeptides, and methods of fermenting cellulosic biomass to produce biofuels, including ethanol.
    Type: Application
    Filed: February 7, 2020
    Publication date: August 6, 2020
    Inventors: Allan Froehlich, Brooks Henningsen
  • Publication number: 20200115697
    Abstract: There is provided an engineered host cells comprising (a) one or more mutations in one or more endogenous genes encoding a protein associated with iron metabolism; and (b) at least one gene encoding a polypeptide having xylose isomerase activity, and methods of their use thereof.
    Type: Application
    Filed: September 18, 2019
    Publication date: April 16, 2020
    Inventors: Allan Froehlich, Brooks Henningsen, Sean Covalla, Rintze M. Zelle
  • Patent number: 10619147
    Abstract: There is provided chimeric polypeptides capable of converting xylose to xylulose, engineered host cells that express the chimeric polypeptides, methods of creating chimeric polypeptides, and methods of fermenting cellulosic biomass to produce biofuels, including ethanol.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: April 14, 2020
    Assignee: Lallemand Hungary Liquidity Management LLC
    Inventors: Allan Froehlich, Brooks Henningsen
  • Publication number: 20200087672
    Abstract: The present disclosure concerns recombinant yeast host cells expressing cell-associated heterologous food and/or feed enzymes which are expressed during the propagation phase of the recombinant yeast hosts cells. The recombinant yeast host cells can be used in a subsequent production process to make food and/or feed products, for example, baked products.
    Type: Application
    Filed: March 13, 2018
    Publication date: March 19, 2020
    Inventors: Aaron Argyros, Michelle Oeser, Erin Wiswall, Janet Fisher, Johannes Van Eijk, J. Kevin Kraus, Kevin Wenger, Brooks Henningsen, Ryan Skinner
  • Patent number: 10465181
    Abstract: There is provided an engineered host cells comprising (a) one or more mutations in one or more endogenous genes encoding a protein associated with iron metabolism; and (b) at least one gene encoding a polypeptide having xylose isomerase activity, and methods of their use thereof.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: November 5, 2019
    Assignee: Lallemand Hungary Liquidity Management LLC
    Inventors: Allan Froehlich, Brooks Henningsen, Sean Covalla, Rintze M. Zelle